After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

"We are deeply disappointed that the (court) misapprehended or failed to take into consideration the clear and convincing evidence that demonstrates that the manufactured supply of semaglutide is ...

Come May 22, compounding pharmacies must stop making semaglutide injections, which serve as a more affordable generic alternative to Ozempic and Wegovy. This decision follows a judge's denial of ...

Novo Nordisk, the pharmaceutical giant that makes Ozempic and Wegovy, emphasizes there is no generic semaglutide currently on the market. "Unapproved fake or illegitimate knockoffs expose patients ...

A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the brands Wegovy and Ozempic.

Since then, he has been covering stories in science and tech. Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study found ...

Researchers estimated that nearly 25,000 ED visits were related to semaglutide adverse events. They were surprised to learn that 16% involved hypoglycemia. An estimated 24,499 people visited the ...

(Semaglutide is the active ingredient in Wegovy ... your doctor may decrease your Wegovy dose to 1.7mg once per week. Here are five possible ways to increase weight loss while using Wegovy ...

Oral semaglutide 14 mg was associated with better cardiometabolic outcomes than active comparators, including empaglifozin and liraglutide, among patients with T2D. Oral semaglutide improves ...

The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide ...